Gene Editing Lifestyle and genetic factors influence risk of cardiovascular complications after COVID-19 Posted on January 11, 2023 by Editorial Staff Researchers examined the contribution of lifestyle and genetic factors to cardiovascular and thromboembolic event (CVE) risk following coronavirus disease 2019 (COVID-19). Share on FacebookTweetFollow us Editorial Staff STAT+: Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy The main source of editing of the mpox virus genome during the 2022 outbreak